vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $42.0M, roughly 1.8× SYNCHRONOSS TECHNOLOGIES INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -2.2%). SYNCHRONOSS TECHNOLOGIES INC produced more free cash flow last quarter ($39.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.7%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

PBYI vs SNCR — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.8× larger
PBYI
$75.5M
$42.0M
SNCR
Growing faster (revenue YoY)
PBYI
PBYI
+30.0% gap
PBYI
27.7%
-2.2%
SNCR
More free cash flow
SNCR
SNCR
$24.6M more FCF
SNCR
$39.0M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
0.7%
SNCR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PBYI
PBYI
SNCR
SNCR
Revenue
$75.5M
$42.0M
Net Profit
$5.8M
Gross Margin
69.3%
79.4%
Operating Margin
22.7%
14.0%
Net Margin
13.8%
Revenue YoY
27.7%
-2.2%
Net Profit YoY
201.7%
EPS (diluted)
$0.26
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SNCR
SNCR
Q4 25
$75.5M
Q3 25
$54.5M
$42.0M
Q2 25
$52.4M
$42.5M
Q1 25
$46.0M
$42.2M
Q4 24
$59.1M
$44.2M
Q3 24
$80.5M
$43.0M
Q2 24
$47.1M
$43.5M
Q1 24
$43.8M
$43.0M
Net Profit
PBYI
PBYI
SNCR
SNCR
Q4 25
Q3 25
$8.8M
$5.8M
Q2 25
$5.9M
$-19.6M
Q1 25
$3.0M
$-3.8M
Q4 24
$7.9M
Q3 24
$20.3M
$-5.7M
Q2 24
$-4.5M
$-494.0K
Q1 24
$-4.8M
$4.5M
Gross Margin
PBYI
PBYI
SNCR
SNCR
Q4 25
69.3%
Q3 25
77.7%
79.4%
Q2 25
76.5%
79.0%
Q1 25
77.1%
79.4%
Q4 24
76.4%
78.6%
Q3 24
63.9%
79.1%
Q2 24
77.4%
76.1%
Q1 24
75.5%
76.2%
Operating Margin
PBYI
PBYI
SNCR
SNCR
Q4 25
22.7%
Q3 25
17.6%
14.0%
Q2 25
12.7%
16.1%
Q1 25
8.7%
19.5%
Q4 24
22.6%
16.5%
Q3 24
27.4%
12.8%
Q2 24
-4.6%
9.9%
Q1 24
-5.3%
10.7%
Net Margin
PBYI
PBYI
SNCR
SNCR
Q4 25
Q3 25
16.2%
13.8%
Q2 25
11.2%
-46.1%
Q1 25
6.5%
-9.0%
Q4 24
17.8%
Q3 24
25.2%
-13.3%
Q2 24
-9.6%
-1.1%
Q1 24
-11.0%
10.4%
EPS (diluted)
PBYI
PBYI
SNCR
SNCR
Q4 25
$0.26
Q3 25
$0.17
$0.51
Q2 25
$0.12
$-1.87
Q1 25
$0.06
$-0.37
Q4 24
$0.40
$0.75
Q3 24
$0.41
$-0.56
Q2 24
$-0.09
$0.01
Q1 24
$-0.10
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$97.5M
$34.8M
Total DebtLower is stronger
$22.7M
$163.2M
Stockholders' EquityBook value
$130.3M
$55.4M
Total Assets
$216.3M
$278.2M
Debt / EquityLower = less leverage
0.17×
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SNCR
SNCR
Q4 25
$97.5M
Q3 25
$94.4M
$34.8M
Q2 25
$96.0M
$24.6M
Q1 25
$93.2M
$29.1M
Q4 24
$101.0M
$33.4M
Q3 24
$96.7M
$25.2M
Q2 24
$96.8M
$23.6M
Q1 24
$107.2M
$19.1M
Total Debt
PBYI
PBYI
SNCR
SNCR
Q4 25
$22.7M
Q3 25
$34.0M
$163.2M
Q2 25
$45.3M
$186.2M
Q1 25
$56.7M
$187.0M
Q4 24
$68.0M
$186.7M
Q3 24
$79.3M
$186.4M
Q2 24
$90.7M
$186.2M
Q1 24
$102.0M
$136.6M
Stockholders' Equity
PBYI
PBYI
SNCR
SNCR
Q4 25
$130.3M
Q3 25
$115.3M
$55.4M
Q2 25
$104.7M
$49.4M
Q1 25
$97.1M
$35.4M
Q4 24
$92.1M
$29.8M
Q3 24
$71.1M
$35.3M
Q2 24
$48.5M
$30.6M
Q1 24
$51.0M
$24.0M
Total Assets
PBYI
PBYI
SNCR
SNCR
Q4 25
$216.3M
Q3 25
$202.9M
$278.2M
Q2 25
$194.9M
$291.4M
Q1 25
$196.2M
$293.3M
Q4 24
$213.3M
$293.8M
Q3 24
$220.7M
$299.7M
Q2 24
$205.0M
$295.7M
Q1 24
$214.1M
$298.5M
Debt / Equity
PBYI
PBYI
SNCR
SNCR
Q4 25
0.17×
Q3 25
0.30×
2.95×
Q2 25
0.43×
3.77×
Q1 25
0.58×
5.28×
Q4 24
0.74×
6.27×
Q3 24
1.12×
5.28×
Q2 24
1.87×
6.08×
Q1 24
2.00×
5.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SNCR
SNCR
Operating Cash FlowLast quarter
$14.4M
$39.4M
Free Cash FlowOCF − Capex
$14.4M
$39.0M
FCF MarginFCF / Revenue
19.1%
92.9%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SNCR
SNCR
Q4 25
$14.4M
Q3 25
$9.7M
$39.4M
Q2 25
$14.1M
$2.3M
Q1 25
$3.6M
$293.0K
Q4 24
$15.6M
$13.1M
Q3 24
$11.0M
$3.4M
Q2 24
$1.0M
$11.3M
Q1 24
$11.2M
$527.0K
Free Cash Flow
PBYI
PBYI
SNCR
SNCR
Q4 25
$14.4M
Q3 25
$9.7M
$39.0M
Q2 25
$14.1M
$2.0M
Q1 25
$3.6M
$-31.0K
Q4 24
$15.6M
$12.2M
Q3 24
$11.0M
$3.2M
Q2 24
$1.0M
$10.9M
Q1 24
$10.0K
FCF Margin
PBYI
PBYI
SNCR
SNCR
Q4 25
19.1%
Q3 25
17.7%
92.9%
Q2 25
26.8%
4.6%
Q1 25
7.7%
-0.1%
Q4 24
26.4%
27.6%
Q3 24
13.7%
7.5%
Q2 24
2.1%
25.2%
Q1 24
0.0%
Capex Intensity
PBYI
PBYI
SNCR
SNCR
Q4 25
0.0%
Q3 25
0.0%
0.9%
Q2 25
0.0%
0.8%
Q1 25
0.1%
0.8%
Q4 24
0.0%
1.9%
Q3 24
0.0%
0.3%
Q2 24
0.0%
0.9%
Q1 24
0.0%
1.2%
Cash Conversion
PBYI
PBYI
SNCR
SNCR
Q4 25
Q3 25
1.10×
6.77×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
1.66×
Q3 24
0.54×
Q2 24
Q1 24
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons